US.CAH · Cardinal Health

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.3996077593922758,
        "turnoverUsdM": 648.7408635335701,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.CAH",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 228.2058,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 0.5,
        "macd_score": 3,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.2,
      "stop_loss_percent": 4.8,
      "take_profit_price": 253.1891,
      "target_multiplier": 1.9,
      "technical_strength": 1.85,
      "take_profit_percent": 5.6
    },
    "positionPoints": 1.6,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 4.7992155187845515,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 70.4,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 63.4,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 7
  },
  "market": {
    "ma20": 228.2815,
    "ma50": 209.0138,
    "close": 239.71,
    "prevClose": 237.52,
    "avgVolume20": 2534588,
    "volumeRatio": 1.07,
    "changePercent": 0.92
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 7,
    "details": {
      "ret_5d": 0.014774405215477238,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 7,
      "vcp_bonus": 0,
      "vol_ratio": 1.091796870272429,
      "ret_points": 4,
      "vol_points": 2,
      "range_ratio": 0.8457066321327648,
      "volat_points": 0,
      "day_range_pct": 0.02171373652689758,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 70.4,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.8,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 56,
        "contribution": 2.8
      },
      {
        "raw": 13.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 66,
        "contribution": 13.2
      },
      {
        "raw": 11.8,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 78.67,
        "contribution": 11.8
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7.4,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 74,
        "contribution": 7.4
      },
      {
        "raw": 22.2,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 74,
        "contribution": 22.2
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 63.4,
    "details": [
      "基本面分析總分: 2.8/5分",
      "資金流分析總分: 13.2/20分",
      "市場環境分析總分: 11.8/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7.4/10分",
      "技術信號分析總分: 22.2/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.8,
      "資金流": 13.2,
      "市場環境": 11.8,
      "情緒分析": 4,
      "技術信號": 22.2,
      "風險管理": 7.4
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0,
          "pePoints": 0.2,
          "epsPoints": 0.75,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 648.7408635335701,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "一般",
        "items": {
          "cmfPoints": 1.6,
          "mfiPoints": 3.2,
          "obvPoints": 2.4,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.CAH",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "良好",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 15.57
            }
          },
          "trend": {
            "score": 2.4,
            "details": {
              "qqq": {
                "ma20": 720.4330052000001,
                "ma50": 711.66400144,
                "name": "QQQ",
                "close": 709.42999,
                "points": 0.4
              },
              "spy": {
                "ma20": 741.2935059,
                "ma50": 739.0122021000002,
                "name": "SPY",
                "close": 747.71002,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.3996077593922758,
          "atrPoints": 3,
          "cciPoints": 4,
          "vixPoints": 2.4,
          "marketTrendPoints": 2.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 3,
              "sentimentScoreRaw": 0.9
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 140835507,
                "url": "https://finnhub.io/api/news?id=1ff4aac3f9d633edc4fe2b43d1c25618d747701c819628733167f2c6c3ec7211",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "In late June 2026, Cardinal Health, Inc. was removed from the Russell 1000 Defensive, Russell 1000 Growth-Defensive, and Russell 1000 Value-Defensive indices, even as it reported quarterly revenue of US$60.94 billion and net profit of US$399 million. At the same time, upbeat commentary from Jim Cramer and reaffirmed positive analyst views highlighted Cardinal Health’s reputation as a healthcare sector stalwart despite its index reclassifications. Next, we’ll examine how this combination of...",
                "category": "company",
                "datetime": 1783459063,
                "headline": "Does Index Removal Amid Solid Results Change The Bull Case For Cardinal Health (CAH)?"
              },
              {
                "id": 140780871,
                "url": "https://finnhub.io/api/news?id=af5080e11481be0b1b046a88ccbc555298fda3756f3f9b31ba119c574a829518",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
                "category": "company",
                "datetime": 1782913203,
                "headline": "Are Investors Undervaluing Cardinal Health (CAH) Right Now?"
              },
              {
                "id": 140741633,
                "url": "https://finnhub.io/api/news?id=b9376dbfc7aa2383ea9838050a2b2f0701962921c40223f60513a60b012f6796",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (CAH) closed at $237.92 in the latest trading session, marking a +1.35% move from the prior day.",
                "category": "company",
                "datetime": 1782511203,
                "headline": "Why the Market Dipped But Cardinal Health (CAH) Gained Today"
              },
              {
                "id": 140725886,
                "url": "https://finnhub.io/api/news?id=6071fc877f1828ad0ea088ee2d2c3749d15131c2db3c0a0c067703f1abb0977f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
                "category": "company",
                "datetime": 1782393302,
                "headline": "Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to Run?"
              },
              {
                "id": 140719975,
                "url": "https://finnhub.io/api/news?id=586a02551aa8e4f4feb36cec3a09a1ea5119f2fe9acbc893ef315202069c820a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "In the latest trading session, Cardinal Health (CAH) closed at $233.01, marking a +1.79% move from the previous day.",
                "category": "company",
                "datetime": 1782339302,
                "headline": "Cardinal Health (CAH) Ascends While Market Falls: Some Facts to Note"
              },
              {
                "id": 140681081,
                "url": "https://finnhub.io/api/news?id=6940f58ce49fa877ec501003c2592cdd5f213528b471084fc790f6539cb8c620",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (CAH) has drawn investor attention after its stock closed at $221.77. This has put recent performance and current valuation metrics in focus for those tracking large U.S. healthcare distributors. See our latest analysis for Cardinal Health. While Cardinal Health’s share price slipped around 2% in the latest session, the 30-day share price return of 10.55% and 1-year total shareholder return of 37.25% sit alongside a very large 5-year total shareholder return of 334.47%. Taken...",
                "category": "company",
                "datetime": 1781986128,
                "headline": "Cardinal Health (CAH) Stock Could Be 9.6% Undervalued Despite Rich P/E Signals"
              },
              {
                "id": 140670077,
                "url": "https://finnhub.io/api/news?id=77483a1986c2444fbad0d762dfd0ec0e9346104b5c753aa6dfc4083fdbd21d63",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health has gained nearly 8% in 2026 as specialty pharma growth, rising EPS, and expanding healthcare services fuel investor optimism.",
                "category": "company",
                "datetime": 1781872560,
                "headline": "CAH Stock Up Nearly 8% YTD: Will the Uptrend Continue in the Rest of 2026?"
              },
              {
                "id": 140666686,
                "url": "https://finnhub.io/api/news?id=1dfe43820a427618d0eeb14a526c47bc2ab4663b28691ab4b7d63b26e6213771",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "In the closing of the recent trading day, Cardinal Health (CAH) stood at $221.77, denoting a -1.99% move from the preceding trading day.",
                "category": "company",
                "datetime": 1781820002,
                "headline": "Cardinal Health (CAH) Stock Declines While Market Improves: Some Information for Investors"
              }
            ],
            "raw_source": [
              {
                "id": 140835507,
                "url": "https://finnhub.io/api/news?id=1ff4aac3f9d633edc4fe2b43d1c25618d747701c819628733167f2c6c3ec7211",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "In late June 2026, Cardinal Health, Inc. was removed from the Russell 1000 Defensive, Russell 1000 Growth-Defensive, and Russell 1000 Value-Defensive indices, even as it reported quarterly revenue of US$60.94 billion and net profit of US$399 million. At the same time, upbeat commentary from Jim Cramer and reaffirmed positive analyst views highlighted Cardinal Health’s reputation as a healthcare sector stalwart despite its index reclassifications. Next, we’ll examine how this combination of...",
                "category": "company",
                "datetime": 1783459063,
                "headline": "Does Index Removal Amid Solid Results Change The Bull Case For Cardinal Health (CAH)?"
              },
              {
                "id": 140822441,
                "url": "https://finnhub.io/api/news?id=a8a1b28066f6e208b8e9c7195cc557e003be78ce757401f35ac4df52844cd88e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Growth premium vs. value recovery, one trades at 33x forward earnings while the other navigates debt reduction and biosimilar expansion.",
                "category": "company",
                "datetime": 1783358941,
                "headline": "Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?"
              },
              {
                "id": 140807781,
                "url": "https://finnhub.io/api/news?id=7d52d19d05cda671822fdd3b1227333a17707b003b922bd120c0f38bcdee2052",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health, Inc. (NYSE:CAH) was among the stocks Jim Cramer commented on as he advised investors on how to take advantage of Wednesday’s market rotation. Cramer said that the stock deserves to “trade higher,” as he commented: Can I call your attention to what may be the best one in this group? I’m talking about […]",
                "category": "company",
                "datetime": 1783174848,
                "headline": "Jim Cramer on Cardinal Health: “It’s Been a Real Stalwart, and I Don’t Think It’s Done”"
              },
              {
                "id": 140801970,
                "url": "https://finnhub.io/api/news?id=8d6fb7d50212e52acef49fd4cca54e09d0c6c76b24dd5b4a0917e964b5baf046",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1886168190/image_1886168190.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "CAH",
                "summary": "Cardinal Health receives a Buy rating, supported by defensive business fundamentals and strong adjusted EPS growth. Read more on CAH stock here.",
                "category": "company",
                "datetime": 1783090514,
                "headline": "Cardinal Health: Why This Essential Healthcare Distributor Deserves A Buy Rating"
              },
              {
                "id": 140793341,
                "url": "https://finnhub.io/api/news?id=7751c4204569198b12c51f40c3f0ddd3f71d55fcc2e968637c26a0615101294c",
                "image": "",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "B of A Securities  analyst Allen Lutz   maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $240 to $260.",
                "category": "company",
                "datetime": 1782990015,
                "headline": "B of A Securities Maintains Buy on Cardinal Health, Raises Price Target to $260"
              },
              {
                "id": 140792257,
                "url": "https://finnhub.io/api/news?id=c695286d7754a1888990f708cd63bc406a376127bc2185825e118715ea2c95c2",
                "image": "https://image.cnbcfm.com/api/v1/image/108329650-4ED3-MM-A-BLOCK-070126.jpg?v=1782947054&w=1920&h=1080",
                "source": "CNBC",
                "related": "CAH",
                "summary": "CNBC's Jim Cramer discusses the day's market action, the stocks he's watching and more.",
                "category": "company",
                "datetime": 1782933515,
                "headline": "Meta's new cloud business will be instantly profitable, says Jim Cramer"
              },
              {
                "id": 140780871,
                "url": "https://finnhub.io/api/news?id=af5080e11481be0b1b046a88ccbc555298fda3756f3f9b31ba119c574a829518",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
                "category": "company",
                "datetime": 1782913203,
                "headline": "Are Investors Undervaluing Cardinal Health (CAH) Right Now?"
              },
              {
                "id": 140781757,
                "url": "https://finnhub.io/api/news?id=5baed29654721b5d98fe3ce501ae03081ebb89e584dc62b245c3de70b534c11e",
                "image": "https://image.cnbcfm.com/api/v1/image/108262197-1770323920909-gettyimages-2260105869-bb1_2632_uxvikxrq.jpeg?v=1782775477&w=1920&h=1080",
                "source": "CNBC",
                "related": "CAH",
                "summary": "The Dow rose more than 300 points on Monday to post its first close above 52,000. Alphabet, a new addition to the 30-stock index, jumped almost 5%.",
                "category": "company",
                "datetime": 1782760725,
                "headline": "Tuesday's big stock stories: What’s likely to move the market in the next trading session"
              },
              {
                "id": 140765129,
                "url": "https://finnhub.io/api/news?id=3b510a05254eac4da2d0a1d40f52879e479eca6c746029ac93824db3dbb6fbc7",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_2.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders often",
                "category": "company",
                "datetime": 1782740122,
                "headline": "10 Health Care Stocks With Whale Alerts In Today’s Session"
              },
              {
                "id": 140760130,
                "url": "https://finnhub.io/api/news?id=771770905477b296fa4e4294e2f84b64324a60ea0b55705f654fc46a6c376942",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2253554625/image_2253554625.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "CAH",
                "summary": "Cardinal Health has experienced a significant surge in share price, surpassing initial expectations. Check out why CAH stock is downgraded to a hold.",
                "category": "company",
                "datetime": 1782709331,
                "headline": "Cardinal Health: I Sold In 2024, Reviewing 2026 (Rating Downgrade)"
              },
              {
                "id": 140744963,
                "url": "https://finnhub.io/api/news?id=d502d3e234636610a86a46fb082cae7d5af2639e1594755baf12d54b8bc8d7f9",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2215519735/image_2215519735.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "CAH",
                "summary": "Dividend Aristocrats beat SPY YTD as June rebounds; CAT tops 2026 gains.",
                "category": "company",
                "datetime": 1782541720,
                "headline": "Best Dividend Aristocrats: June 2026"
              },
              {
                "id": 140741633,
                "url": "https://finnhub.io/api/news?id=b9376dbfc7aa2383ea9838050a2b2f0701962921c40223f60513a60b012f6796",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (CAH) closed at $237.92 in the latest trading session, marking a +1.35% move from the prior day.",
                "category": "company",
                "datetime": 1782511203,
                "headline": "Why the Market Dipped But Cardinal Health (CAH) Gained Today"
              },
              {
                "id": 140740729,
                "url": "https://finnhub.io/api/news?id=e2ecfe7423e0385e993151624a54a5d758f2b095b51c5e3aa85f275016df6d8d",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "CAH",
                "summary": "A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read it here.",
                "category": "company",
                "datetime": 1782496544,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of June 28"
              },
              {
                "id": 140734106,
                "url": "https://finnhub.io/api/news?id=33e53e5381c4216d870fded2f16d62acab6bee5d76be358850e320e4777180e0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.",
                "category": "company",
                "datetime": 1782465625,
                "headline": "2 Large-Cap Stocks Worth Your Attention and 1 We Brush Off"
              },
              {
                "id": 140729431,
                "url": "https://finnhub.io/api/news?id=a39ed9ec0df153be4a5560c97317f1cb46625a61f77315297ea5701c0fb1f3d1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "AbbVie and Pfizer are taking divergent paths to navigate patent expirations and competition. Dig into their financials, risk profiles, and valuation metrics.",
                "category": "company",
                "datetime": 1782422101,
                "headline": "AbbVie vs. Pfizer: Which Pharma Giant Stock Is a Better Buy in 2026?"
              },
              {
                "id": 140725885,
                "url": "https://finnhub.io/api/news?id=63e796a101b47229f98ad062ae6379b2b0a2a93a64e0cad3050f18d5d418d333",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Here is how Bayer Aktiengesellschaft (BAYRY) and Cardinal Health (CAH) have performed compared to their sector so far this year.",
                "category": "company",
                "datetime": 1782394803,
                "headline": "Is Bayer (BAYRY) Outperforming Other Medical Stocks This Year?"
              },
              {
                "id": 140725886,
                "url": "https://finnhub.io/api/news?id=6071fc877f1828ad0ea088ee2d2c3749d15131c2db3c0a0c067703f1abb0977f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
                "category": "company",
                "datetime": 1782393302,
                "headline": "Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to Run?"
              },
              {
                "id": 140720698,
                "url": "https://finnhub.io/api/news?id=ddf50b1ac73dc72ba5f8c158f9c66e02784aa8e5fa11b8926321ce4419feff23",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Micron surged overnight on strong earnings and guidance, lifting other memory and chip plays. The Fed's favorite inflation gauge is on tap.",
                "category": "company",
                "datetime": 1782352340,
                "headline": "Dow Jones Futures: Micron Earnings Send Sandisk, Techs Soaring; Fed Inflation Data Due"
              },
              {
                "id": 140719975,
                "url": "https://finnhub.io/api/news?id=586a02551aa8e4f4feb36cec3a09a1ea5119f2fe9acbc893ef315202069c820a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "In the latest trading session, Cardinal Health (CAH) closed at $233.01, marking a +1.79% move from the previous day.",
                "category": "company",
                "datetime": 1782339302,
                "headline": "Cardinal Health (CAH) Ascends While Market Falls: Some Facts to Note"
              },
              {
                "id": 140718279,
                "url": "https://finnhub.io/api/news?id=a43e10cf1cc704c28a80e478e4e4c801a50c5b9c2d2397ea54908978f5f5637a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Micron surged overnight on strong earnings and guidance, lifting other memory and chip plays. The Fed's favorite inflation gauge is on tap.",
                "category": "company",
                "datetime": 1782337810,
                "headline": "Dow Jones Futures Rise As Micron Jumps On Earnings, Lifting Sandisk, AI Stocks; Fed Inflation Data Due"
              },
              {
                "id": 140712985,
                "url": "https://finnhub.io/api/news?id=10d2bf69a9b97ed3b249d31d72dfcc503efbeb04260955f09a954feae93c3b65",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Neonatal Intensive Care Respiratory Devices Market size & share revenue was valued at approximately USD 2.1 Billion in 2025 and is expected to reach USD 2.3 Billion in 2026 and is expected to reach around USD 5.7 Billion by 2035, at a CAGR of 10.5% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Inspirat",
                "category": "company",
                "datetime": 1782307800,
                "headline": "[Latest] Global Neonatal Intensive Care Respiratory Devices Market Size/Share Worth USD 5.7 Billion by 2035 at a 10.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis)"
              },
              {
                "id": 140708402,
                "url": "https://finnhub.io/api/news?id=b3a7ee6a350df0ab5045806e8cc4f478188c906b0fc0f9f97044a1311ca39092",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Weigh the financial strength of a pharma leader against the rapid growth, and risks, of a biotech newcomer as both navigate industry headwinds.",
                "category": "company",
                "datetime": 1782258787,
                "headline": "Amgen vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 140681081,
                "url": "https://finnhub.io/api/news?id=6940f58ce49fa877ec501003c2592cdd5f213528b471084fc790f6539cb8c620",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (CAH) has drawn investor attention after its stock closed at $221.77. This has put recent performance and current valuation metrics in focus for those tracking large U.S. healthcare distributors. See our latest analysis for Cardinal Health. While Cardinal Health’s share price slipped around 2% in the latest session, the 30-day share price return of 10.55% and 1-year total shareholder return of 37.25% sit alongside a very large 5-year total shareholder return of 334.47%. Taken...",
                "category": "company",
                "datetime": 1781986128,
                "headline": "Cardinal Health (CAH) Stock Could Be 9.6% Undervalued Despite Rich P/E Signals"
              },
              {
                "id": 140672156,
                "url": "https://finnhub.io/api/news?id=316fd024f5fb9ffa66ea7460855c76ed20c567cbaf57adbbc1d65a5ba37927ed",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Amgen posts strong profits and cash flow, while NovoCure pursues growth with a direct-to-patient cancer therapy model and leaner balance sheet.",
                "category": "company",
                "datetime": 1781889034,
                "headline": "Amgen vs. NovoCure: Which Health Care Stock Is a Better Buy in 2026?"
              },
              {
                "id": 140670077,
                "url": "https://finnhub.io/api/news?id=77483a1986c2444fbad0d762dfd0ec0e9346104b5c753aa6dfc4083fdbd21d63",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health has gained nearly 8% in 2026 as specialty pharma growth, rising EPS, and expanding healthcare services fuel investor optimism.",
                "category": "company",
                "datetime": 1781872560,
                "headline": "CAH Stock Up Nearly 8% YTD: Will the Uptrend Continue in the Rest of 2026?"
              },
              {
                "id": 140666686,
                "url": "https://finnhub.io/api/news?id=1dfe43820a427618d0eeb14a526c47bc2ab4663b28691ab4b7d63b26e6213771",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "In the closing of the recent trading day, Cardinal Health (CAH) stood at $221.77, denoting a -1.99% move from the preceding trading day.",
                "category": "company",
                "datetime": 1781820002,
                "headline": "Cardinal Health (CAH) Stock Declines While Market Improves: Some Information for Investors"
              },
              {
                "id": 140664070,
                "url": "https://finnhub.io/api/news?id=6d9943dc90e818f99e50146e5d1610165de152f4f7714dcf9fcf8ff7f8cb4118",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Closed System Drug Transfer Devices Market size & share revenue was valued at approximately USD 1.47 Billion in 2025 and is expected to reach USD 1.58 Billion in 2026 and is expected to reach around USD 3.21 Billion by 2035, at a CAGR of 8.3% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are BD (Becton Dic",
                "category": "company",
                "datetime": 1781803800,
                "headline": "Global Closed System Drug Transfer Devices Market Size/Share Worth USD 3.21 Billion by 2035 at a 8.3% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)"
              },
              {
                "id": 140664196,
                "url": "https://finnhub.io/api/news?id=44be2be72418cae135bcebd527ed2c7099c025f77f83a5ccac5939b911f80b2b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "COR shares are down 18% YTD, but rising EPS guidance, specialty pharma growth and strategic expansion could make this pullback worth watching.",
                "category": "company",
                "datetime": 1781801340,
                "headline": "COR Stock Down Nearly 18% YTD: Should You Buy, Hold or Sell?"
              },
              {
                "id": 140663240,
                "url": "https://finnhub.io/api/news?id=502be8cfa56fb7c98ab7e6cc158a5110bc80b803526d64422f5ca40489a60e38",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Based on the average brokerage recommendation (ABR), Cardinal (CAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?",
                "category": "company",
                "datetime": 1781789403,
                "headline": "Is It Worth Investing in Cardinal (CAH) Based on Wall Street's Bullish Views?"
              },
              {
                "id": 140662603,
                "url": "https://finnhub.io/api/news?id=9d4c432e1452449c97a03240c0ed5630a76d3832ed7543dbaeaa6a1adf4bd1d8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.",
                "category": "company",
                "datetime": 1781788648,
                "headline": "1 Cash-Producing Stock to Target This Week and 2 Facing Headwinds"
              },
              {
                "id": 140648039,
                "url": "https://finnhub.io/api/news?id=15d6a6da3b9d3800527810852b9cb36443de1cbe24001fad935a1b3e373c974f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "BAX is pursuing a broad turnaround as innovation, resilient demand, and AI integration support recovery despite regulatory risks and margin pressure.",
                "category": "company",
                "datetime": 1781633640,
                "headline": "Reasons to Retain Baxter International Stock in Your Portfolio for Now"
              },
              {
                "id": 140645722,
                "url": "https://finnhub.io/api/news?id=8609db04e140777425e1b39bcadd535acf2b839741f5f4815bf0bf3fcc060be3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Becton, Dickinson's MedTech focus, innovation push and strategic partnerships support growth optimism, though reimbursement uncertainty remains a key concern.",
                "category": "company",
                "datetime": 1781618040,
                "headline": "Here's Why You Should Retain BDX Stock in Your Portfolio Now"
              },
              {
                "id": 140640551,
                "url": "https://finnhub.io/api/news?id=8d4fd4a4513a3c5b73d055c80e3d1d3bb523365a5e7b3fff09441f49927cb770",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health has outperformed the healthcare sector over the past year. Moreover, Wall Street analysts are strongly bullish on the stock.",
                "category": "company",
                "datetime": 1781538446,
                "headline": "Cardinal Health Stock: Is CAH Outperforming the Healthcare Sector?"
              },
              {
                "id": 140638282,
                "url": "https://finnhub.io/api/news?id=a1bab28e98cdc5d5897489cc92d83d4639b953768106bd4b3aaab3b56dacbd77",
                "image": "https://cdn.benzinga.com/files/images/story/2026/06/15/Healthcare-stocks.jpeg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "3 health care stocks flashing warning: CAH RSI 77.7, TGTX RSI 79.8, AMRX RSI 76.9; all overbought, but positive price action for TGTX.",
                "category": "company",
                "datetime": 1781513465,
                "headline": "Top 3 Health Care Stocks That May Collapse This Quarter"
              },
              {
                "id": 140621746,
                "url": "https://finnhub.io/api/news?id=d41d25da43b74e3068e20e63e981f5de87afdbf670dc0272d399431273931bb8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Stryker faces cyberattack fallout, but strong procedure demand, record Mako adoption and global expansion continue to support long-term growth.",
                "category": "company",
                "datetime": 1781284560,
                "headline": "Here's Why You Should Hold Stryker Stock in Your Portfolio for Now"
              },
              {
                "id": 140618897,
                "url": "https://finnhub.io/api/news?id=4b7cf6df9522e704a879b0150509ab96879c2019ad57c2573f4a059977dfa0df",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
                "category": "company",
                "datetime": 1781271603,
                "headline": "Is Cardinal Health (CAH) Stock Undervalued Right Now?"
              },
              {
                "id": 140581290,
                "url": "https://finnhub.io/api/news?id=5848230ddd69b3175e11dfa785ec4fe9db101fc972474b4399104f057363a502",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Italian healthcare vials and cartridges maker Stevanato Group and U.S. generic and wholesale pharmaceutical company Cencora are two of the best healthcare buys right now.",
                "category": "company",
                "datetime": 1781017500,
                "headline": "2 Dirt Cheap Healthcare Stocks to Buy With $1,000 Right Now"
              },
              {
                "id": 140570951,
                "url": "https://finnhub.io/api/news?id=31e63f39be520a807148961c7e0729b6d5c57029ec4ac9e04be975777c21b476",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "A new, smaller 60 mL bottle brings pharmacy-stocking and dosing convenience to a once-daily liquid amphetamine designed for individualized titration in ADHDMONMOUTH JUNCTION, N.J., June 08, 2026 (GLOBE NEWSWIRE) -- Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company advancing transformative targeted CNS therapeutics, today announced the availability of DYANAVEL® XR (amphetamine) extended-release oral suspension, CII (2.5 mg/mL) in a new, smaller 60 mL bottle (NDC 24478-102-02)",
                "category": "company",
                "datetime": 1780938720,
                "headline": "Tris Pharma Introduces a New 60 mL Bottle Size for DYANAVEL® XR (amphetamine) Extended-Release Oral Suspension CII"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 3,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.9,
            "source_article_count": 38,
            "discarded_article_count": 27
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 22.2,
        "grade": "良好",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 2.1,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 2.1,
            "vcp_reason": "波幅收縮(20%→8.2%)；站上MA50；升放量(近10日2日)；Ready=N；Confirm=Y",
            "vcp_metrics": {
              "up_days": 7,
              "vol_ref": 2298066.6666666665,
              "down_days": 2,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 2253720,
              "avg_vol_20": 2478810,
              "avg_vol_30": 2298066.6666666665,
              "range_pct_10": 0.08168202904834893,
              "range_pct_20": 0.17045596051662595,
              "range_pct_30": 0.19965791165750654,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": false,
              "up_expand_days": 2,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.9807026195932814,
              "dist_to_20d_high": 0.008889398825766982,
              "down_shrink_days": 1,
              "breakout_level_20d": 241.86,
              "vcp_breakout_confirm": true,
              "contraction_ratio_10_30": 0.4091099038863353
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 1,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.3996077593922758,
              "turnoverUsdM": 648.7408635335701,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.CAH",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 228.2058,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 0.5,
              "macd_score": 3,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.2,
            "stop_loss_percent": 4.8,
            "take_profit_price": 253.1891,
            "target_multiplier": 1.9,
            "technical_strength": 1.85,
            "take_profit_percent": 5.6
          },
          "positionPoints": 1.6,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 4.7992155187845515,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 92.86,
    "atr": {
      "atr": 5.7521,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.4
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "強勢區",
      "score": 10,
      "value": 98.85
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "平衡",
      "score": 4,
      "value": 0.053
    },
    "kdj": {
      "d": 82.94,
      "j": 75.02,
      "k": 80.3,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "入貨中",
      "score": 8,
      "value": 65.11
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 6,
      "trend": "有流入",
      "value": 26223757,
      "recentSlope": 1143995.7,
      "previousSlope": 1601950
    },
    "rsi": 71.16,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 237.9017,
      "position": "SAR喺價下",
      "distancePct": 0.75,
      "previousTrend": "上升"
    },
    "ma50": 209.0138,
    "macd": {
      "macd": 8.862471622937534,
      "trend": "強烈看漲",
      "signal": 8.479928185924846,
      "histogram": 0.38254343701268745
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 227.3441,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 35
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.07,
      "score": 6,
      "avgVolume": 2534588,
      "currentVolume": 2706357
    },
    "derived": {
      "ma20": 228.2815,
      "ma50": 209.0138,
      "prevClose": 237.52,
      "avgVolume10": 2235756,
      "avgVolume20": 2534588,
      "changePercent": 0.92,
      "avgVolumeForScore": 2534588
    },
    "ma_cross": {
      "ma20": 228.2815,
      "ma50": 209.0138,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 226.5815,
      "prevMa50": 208.314,
      "spreadPct": 9.22,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 209.1485,
      "upper": 247.4145,
      "position": "上半部"
    },
    "rsi_short": 61.15,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.07
    }
  }
}

{
  "close": 239.71,
  "volume": 2706357,
  "changePercent": 0.92
}